Catalyst Wire Dossier Catalyst Wire Dossier

Evkeeza

evinacumab · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Evkeeza, covering 2021-02-11 to 2026-07-09. Get the full timeline:

Most recent: EMA Authorised: Evkeeza (Evinacumab) — Ultragenyx Germany GmbH

See pricing